Genex Pharmaceutical, Inc. (GENX)
OTC
Healthcare
Medical - Specialties
$0.00
▲ +0.00%
Market Cap
$1,788
Sector
Healthcare
Industry
Medical - Specialties
Beta
-0.43
52-Wk Range
0.000099999997-0.0002
CEO
Fuzhi Song
Country
CN
Currency
USD
Genex Pharmaceutical, Inc. operates in the Medical - Specialties industry of the Healthcare sector, headquartered in Tianjin, TX, CN. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $1,788. On trailing twelve-month figures it carries a trailing P/E of 0.01, a net margin of 10.6%. Its beta of -0.43 implies it has historically moved less than the broad market.
Valuation & profitability (TTM)
P/E
0.01
Price / Sales
0.00
Price / Book
0.00
EV / EBITDA
-0.54
Gross margin
88.8%
Operating margin
14.4%
Net margin
10.6%
Return on equity
—
Debt / equity
0.00
Current ratio
0.62
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
86
IPO date
2004-03-29
Headquarters
Tianjin, TX, CN
About Genex Pharmaceutical, Inc.
Genex Pharmaceutical, Inc. engages in the development and production of Reconstituted Bone Xenograft, which is a medical device that accelerates bone healing. The company was founded on February 28, 2002 and is headquartered in Tianjin, China.
Comparable companies
Genex Pharmaceutical, Inc. is most often compared with the following Healthcare names:
More research on GENX
Open full interactive analysis & DCF →